390 related articles for article (PubMed ID: 22974104)
21. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
[TBL] [Abstract][Full Text] [Related]
22. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
[TBL] [Abstract][Full Text] [Related]
23. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
[TBL] [Abstract][Full Text] [Related]
24. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
[TBL] [Abstract][Full Text] [Related]
25. [Translational research and diagnosis in GIST].
Wardelmann E
Pathologe; 2012 Nov; 33 Suppl 2():273-7. PubMed ID: 22968735
[TBL] [Abstract][Full Text] [Related]
26. Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).
Nannini M; Astolfi A; Urbini M; Indio V; Santini D; Heinrich MC; Corless CL; Ceccarelli C; Saponara M; Mandrioli A; Lolli C; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Cancer; 2014 Sep; 14():685. PubMed ID: 25239601
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
28. Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case.
Belinsky MG; Rink L; Cai KQ; Capuzzi SJ; Hoang Y; Chien J; Godwin AK; von Mehren M
BMC Cancer; 2015 Nov; 15():887. PubMed ID: 26555092
[TBL] [Abstract][Full Text] [Related]
29. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
Miettinen M; Lasota J
Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
[TBL] [Abstract][Full Text] [Related]
30. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.
Gaal J; Stratakis CA; Carney JA; Ball ER; Korpershoek E; Lodish MB; Levy I; Xekouki P; van Nederveen FH; den Bakker MA; O'Sullivan M; Dinjens WN; de Krijger RR
Mod Pathol; 2011 Jan; 24(1):147-51. PubMed ID: 20890271
[TBL] [Abstract][Full Text] [Related]
31. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
33. Molecular characterization of pediatric gastrointestinal stromal tumors.
Agaram NP; Laquaglia MP; Ustun B; Guo T; Wong GC; Socci ND; Maki RG; DeMatteo RP; Besmer P; Antonescu CR
Clin Cancer Res; 2008 May; 14(10):3204-15. PubMed ID: 18483389
[TBL] [Abstract][Full Text] [Related]
34. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.
Urbini M; Indio V; Tarantino G; Ravegnini G; Angelini S; Nannini M; Saponara M; Santini D; Ceccarelli C; Fiorentino M; Vincenzi B; Fumagalli E; Casali PG; Grignani G; Pession A; Ardizzoni A; Astolfi A; Pantaleo MA
Genes Chromosomes Cancer; 2019 Sep; 58(9):636-642. PubMed ID: 30887595
[TBL] [Abstract][Full Text] [Related]
35. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.
Boikos SA; Stratakis CA
Endocrine; 2014 Nov; 47(2):401-8. PubMed ID: 25027296
[TBL] [Abstract][Full Text] [Related]
36. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
[TBL] [Abstract][Full Text] [Related]
37. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor With SDHC Germline Mutation and Bilateral Renal and Neck Cysts.
Stanley K; Friehling E; Davis A; Ranganathan S
Pediatr Dev Pathol; 2019; 22(3):265-268. PubMed ID: 30301441
[TBL] [Abstract][Full Text] [Related]
38. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
[TBL] [Abstract][Full Text] [Related]
39. Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST.
Urbini M; Astolfi A; Indio V; Nannini M; Schipani A; Bacalini MG; Angelini S; Ravegnini G; Calice G; Del Gaudio M; Secchiero P; Ulivi P; Gruppioni E; Pantaleo MA
Sci Rep; 2020 Nov; 10(1):19829. PubMed ID: 33199729
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
